HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 185 studies to date is estimated to be 1 in 19 quadrillion. Early treatment is most successful, with 100% of studies reporting a positive effect and an estimated reduction of 65% in the effect measured (death, hospitalization, etc.) using a random effects meta-analysis.